ArticleFrontiers in molecular biosciences2022
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world.
Serena Di Cosimo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it